GridAI Technologies GRDX Peer Comparison

NASDAQ GRDX
$3.02 +0.00 (+0.00%)
As of: Sep 10, 2026 · 1:24 PM EDT
Peer Comparison

300 Comparable Companies

Industry Biotechnology

The table below compares all 300 Biotechnology companies on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 AMGN Amgen Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 206.09 Bn 23.57 5.41 192.10 Bn
2 GILD Gilead Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 179.75 Bn -62.09 5.90 176.57 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma primary H-02 Pharmaceuticals and Biotechnology HG-01 131.11 Bn 29.76 10.42 123.26 Bn
4 REGN Regeneron Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 81.77 Bn 18.89 5.26 73.78 Bn
5 ARGX Argenx Se primary H-02 Pharmaceuticals and Biotechnology HG-01 60.45 Bn 35.24 11.57 55.27 Bn
6 MRNA Moderna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 53.60 Bn -17.01 24.06 48.46 Bn
7 ALNY Alnylam Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 33.36 Bn 43.07 6.94 30.06 Bn
8 BIIB Biogen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 31.72 Bn 38.01 3.16 30.44 Bn
9 ROIV Roivant Sciences Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 29.09 Bn -19.60 2,662.91 29.09 Bn
10 INSM INSMED Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 27.62 Bn -31.55 24.27 26.46 Bn
11 BNTX BioNTech SE primary H-02 Pharmaceuticals and Biotechnology HG-01 23.26 Bn -13.65 7.52 9.61 Bn
12 ASND Ascendis Pharma A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 15.81 Bn 18.24 11.15 14.87 Bn
13 MDGL Madrigal Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 15.43 Bn -48.38 12.02 14.59 Bn
14 BBIO BridgeBio Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 14.33 Bn -20.71 20.09 13.61 Bn
15 SMMT Summit Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 13.31 Bn — — 12.62 Bn
16 BMRN Biomarin Pharmaceutical Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.60 Bn 172.64 3.70 11.72 Bn
17 HALO Halozyme Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.57 Bn 30.41 7.56 12.34 Bn
18 ARWR Arrowhead Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 11.86 Bn -43.58 17.71 10.26 Bn
19 AAVXF Abivax S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
20 APGE Apogee Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
21 PRAX Praxis Precision Medicines, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 9.89 Bn -25.93 — 9.13 Bn
22 PTGX Protagonist Therapeutics, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.62 Bn 87.15 34.12 9.62 Bn
23 IONS Ionis Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.15 Bn -43.10 10.47 7.09 Bn
24 PCVX Vaxcyte, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.56 Bn -8.10 — 8.56 Bn
25 IBRX ImmunityBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.10 Bn -8.16 48.86 7.74 Bn
26 TGTX Tg Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.75 Bn 17.54 9.69 7.07 Bn
27 IMVT Immunovant, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.73 Bn -14.36 — 7.73 Bn
28 GIFLF Grifols SA primary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
29 SYRE Spyre Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.41 Bn -41.42 — 7.41 Bn
30 SRRK Scholar Rock Holding Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 7.30 Bn -18.08 — 7.30 Bn
31 RYTM Rhythm Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.00 Bn -33.28 29.16 6.67 Bn
32 BLRX BioLineRx Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.35 Bn -708.81 4,560.40 6.35 Bn
33 CGON CG Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.30 Bn -28.12 1,012.15 6.30 Bn
34 MIRM Mirum Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.30 Bn -7.32 10.19 5.86 Bn
35 KNSA Kiniksa Pharmaceuticals International, plc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.93 Bn 73.56 7.06 5.41 Bn
36 XENE Xenon Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.89 Bn -16.24 — 5.89 Bn
37 LGND Ligand Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.79 Bn 29.35 19.92 4.43 Bn
38 COGT Cogent Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn -15.63 — 5.78 Bn
39 ORKA Oruka Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.72 Bn — — 3.99 Bn
40 DBVT DBV Technologies S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.67 Bn -32.22 1,129.84 5.50 Bn
41 PTCT Ptc Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.60 Bn 14.63 5.55 3.37 Bn
42 ERAS Erasca, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.97 Bn -17.30 — 4.97 Bn
43 CELC Celcuity Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.72 Bn -21.56 — 4.72 Bn
44 DNLI Denali Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.99 Bn -7.80 1,106.53 3.99 Bn
45 DNTH Dianthus Therapeutics, Inc. /DE/ primary H-02 Pharmaceuticals and Biotechnology HG-01 3.98 Bn — — 3.58 Bn
46 TLPPF Telix Pharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
47 RLAY Relay Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.82 Bn -13.35 368.85 3.82 Bn
48 VKTX Viking Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.77 Bn -7.05 — 3.77 Bn
49 AMLX Amylyx Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.59 Bn -29.55 — 3.59 Bn
50 TNGX Tango Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.53 Bn -34.48 65.58 2.51 Bn
51 IDYA IDEAYA Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.51 Bn -15.95 15.00 2.68 Bn
52 RCUS Arcus Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.42 Bn -7.45 29.27 2.72 Bn
53 ABCL AbCellera Biologics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.31 Bn -20.08 49.96 3.31 Bn
54 ARQT Arcutis Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.05 Bn 107.23 6.58 2.82 Bn
55 CLDX Celldex Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn -9.77 19,011.68 3.00 Bn
56 DYN Dyne Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn -5.81 — 3.00 Bn
57 MBX MBX Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -28.38 — 2.96 Bn
58 IMNM Immunome Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.90 Bn -10.73 593.06 2.38 Bn
59 IRON Disc Medicine, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.86 Bn -14.20 — 2.86 Bn
60 NRIX Nurix Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.84 Bn -8.32 77.26 2.40 Bn
61 ZLAB Zai Lab Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.74 Bn -14.58 6.10 2.04 Bn
62 SLS SELLAS Life Sciences Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.59 Bn -79.79 — 2.59 Bn
63 OCUL Ocular Therapeutix, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -8.07 46.95 2.44 Bn
64 VERA Vera Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn -6.02 — 2.41 Bn
65 XTLB Xtl Biopharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2,975.41 — 2.38 Bn
66 NKTR Nektar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -20.04 43.62 1.70 Bn
67 VRDN Viridian Therapeutics, Inc.\DE primary H-02 Pharmaceuticals and Biotechnology HG-01 2.32 Bn -5.81 32.67 2.32 Bn
68 PHVS Pharvaris N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.26 Bn -11.39 — 1.89 Bn
69 URGN UroGen Pharma Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn -34.73 11.46 2.05 Bn
70 ADMA Adma Biologics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn 12.92 4.19 2.01 Bn
71 BCRX Biocryst Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.10 Bn -5.45 3.92 1.74 Bn
72 GMAB Genmab A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 2.09 Bn 0.17 0.33 0.59 Bn
73 RAPP Rapport Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.07 Bn -15.08 103.44 2.07 Bn
74 KOD Kodiak Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.05 Bn -8.47 — 2.05 Bn
75 AGIO Agios Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.99 Bn -4.83 20.21 1.99 Bn
76 ZBIO Zenas BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -4.76 1,978.57 1.98 Bn
77 ZYME Zymeworks Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.95 Bn -13.01 52.57 1.68 Bn
78 CMPS COMPASS Pathways plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -4.90 — 1.93 Bn
79 STOK Stoke Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -9.27 69.79 1.63 Bn
80 BHVN Biohaven Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.89 Bn -3.22 — 1.62 Bn
81 XNCR Xencor Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn -11.18 17.40 1.45 Bn
82 VIR Vir Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.79 Bn -7.12 5.91 1.79 Bn
83 INBX Inhibrx Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn -13.07 1,341.33 1.74 Bn
84 GLPGF Lakefront Biotherapeutics NV primary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
85 SEPN Septerna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -122.78 17.34 1.71 Bn
86 IMCR Immunocore Holdings plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -94.41 3.97 0.83 Bn
87 RXRX Recursion Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.70 Bn -3.27 30.92 1.14 Bn
88 DMRA Damora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.67 Bn -6.34 — 1.13 Bn
89 SNDX Syndax Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -9.11 6.54 1.10 Bn
90 GHRS GH Research PLC primary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -26.50 — 1.29 Bn
91 ATAI AtaiBeckley Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -10.37 525.54 1.60 Bn
92 BCAX Bicara Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -8.51 — 1.58 Bn
93 FBRX Forte Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
94 ANAB Anaptysbio, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -65.57 7.86 1.28 Bn
95 SCNI Scinai Immunotherapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.55 Bn -184.54 897.61 1.54 Bn
96 NVAX Novavax Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -6.11 3.66 0.79 Bn
97 AAPG Ascentage Pharma Group International primary H-02 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -9.11 20.12 1.21 Bn
98 TYRA Tyra Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -9.91 — 1.47 Bn
99 MAZE Maze Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -13.82 73.27 1.47 Bn
100 RARE Ultragenyx Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -3.16 2.04 1.17 Bn
101 GLUE Monte Rosa Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -9.35 50.09 0.81 Bn
102 AVBP ArriVent BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.39 Bn -8.49 — 1.39 Bn
103 ANRO Alto Neuroscience, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -16.38 — 1.37 Bn
104 SVRA Savara Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.35 Bn -9.67 — 1.35 Bn
105 OMER Omeros Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn 78.44 34.84 1.34 Bn
106 ORIC Oric Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.32 Bn -8.42 — 1.32 Bn
107 REPL Replimune Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.31 Bn -4.43 — 1.31 Bn
108 ABSI Absci Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.30 Bn -10.77 835.29 1.10 Bn
109 CGEM Cullinan Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.30 Bn -6.35 — 1.30 Bn
110 ALMS Alumis Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -5.18 150.74 0.75 Bn
111 VOR Vor Biopharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -1.33 — 1.22 Bn
112 CRVS Corvus Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.20 Bn -25.19 — 0.99 Bn
113 MNKD Mannkind Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -26.96 2.99 1.06 Bn
114 JBIO Jade Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -7.59 — 1.16 Bn
115 JANX Janux Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -11.28 48.23 1.16 Bn
116 CLYM Climb Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.10 Bn -19.14 — 1.10 Bn
117 ABUS Arbutus Biopharma Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 6.62 5.55 0.92 Bn
118 MLTX MoonLake Immunotherapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -3.70 — 0.45 Bn
119 OKYO OKYO Pharma Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -118.02 — 0.98 Bn
120 WVE Wave Life Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.96 Bn -4.74 14.68 0.59 Bn
121 MNPR Monopar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -68.07 — 0.89 Bn
122 GERN Geron Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.92 Bn -13.69 3.78 0.62 Bn
123 ARDX Ardelyx, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.91 Bn -16.32 2.02 0.63 Bn
124 TBPH Theravance Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.81 8.44 0.49 Bn
125 RIGL Rigel Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn 2.69 3.13 0.77 Bn
126 ANNX Annexon, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.83 Bn -4.06 — 0.83 Bn
127 STTK Shattuck Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -15.00 809.82 0.81 Bn
128 AVTX Avalo Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -7.77 — 0.78 Bn
129 ACRS Aclaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -9.77 94.56 0.78 Bn
130 CTMX CytomX Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.75 Bn -9.83 40.73 0.42 Bn
131 PHAR Pharming Group N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -119.85 2.24 0.58 Bn
132 ZURA Zura Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn -5.98 — 0.70 Bn
133 AURA Aura Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.66 Bn -6.03 — 0.59 Bn
134 IRWD Ironwood Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 2.94 1.67 0.57 Bn
135 SLN Silence Therapeutics plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -16.20 1,023.84 0.56 Bn
136 ALT Altimmune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -8.20 — 0.61 Bn
137 SGMT Sagimet Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -12.39 — 0.60 Bn
138 CBIO Crescent Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -3.65 573.03 0.42 Bn
139 OCS Oculis Holding AG primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -337,225.82 — 0.59 Bn
140 ASMB Assembly Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 466.79 7.76 0.26 Bn
141 VALN Valneva SE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.77 3.42 0.43 Bn
142 ARVN Arvinas, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn 60.41 1.77 -0.01 Bn
143 CTNM Contineum Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -9.30 — 0.56 Bn
144 TECX Tectonic Therapeutic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -6.33 — 0.54 Bn
145 OABI OmniAb, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -11.64 13.40 0.46 Bn
146 IMUX Immunic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -4.39 — 0.51 Bn
147 ANL Adlai Nortye Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn -10.27 78.36 0.26 Bn
148 PRLD Prelude Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -7.15 21.50 0.20 Bn
149 PRTA Prothena Corp Public Ltd Co primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -10.81 8.71 0.19 Bn
150 PBYI Puma Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 15.56 2.02 0.37 Bn
151 NEUP Neuphoria Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.62 — 0.45 Bn
152 KMDA Kamada Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 14.87 2.41 0.39 Bn
153 RLMD Relmada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -7.51 — 0.46 Bn
154 BBOT BridgeBio Oncology Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -2.28 — 0.23 Bn
155 DRUG Bright Minds Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -15.20 — 0.44 Bn
156 CCCC C4 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -4.29 12.40 0.18 Bn
157 RZLT Rezolute, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -5.33 — 0.43 Bn
158 AVIR Atea Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.08 — 0.42 Bn
159 ARCT Arcturus Therapeutics Holdings Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.22 13.70 0.21 Bn
160 EVMN Evommune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.18 39.59 0.20 Bn
161 BIOA BioAge Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.19 37.98 0.39 Bn
162 LRMR Larimar Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -2.23 — 0.24 Bn
163 CMPX Compass Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.80 — 0.39 Bn
164 HMDCF HUTCHMED (China) Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
165 ENTA Enanta Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn -5.87 5.67 0.18 Bn
166 EYPT EyePoint, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -1.16 128.62 0.18 Bn
167 DMAC DiaMedica Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -10.31 — 0.34 Bn
168 WHWK Whitehawk Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -4.26 — 0.34 Bn
169 CATX Perspective Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -2.81 — 0.34 Bn
170 EPRX Eupraxia Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -6.45 — 0.32 Bn
171 FHTX Foghorn Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -4.84 8.65 0.25 Bn
172 ELDN Eledon Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.80 — 0.32 Bn
173 UPB Upstream Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -1.97 99.70 0.31 Bn
174 STRO Sutro Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -2.58 3.27 0.13 Bn
175 AGEN Agenus Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 3.13 2.17 0.29 Bn
176 EQ Equillium, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -15.42 — 0.28 Bn
177 SABS SAB Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -4.01 — 0.27 Bn
178 ACIU AC Immune SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -5.07 12.40 0.27 Bn
179 TRDA Entrada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -1.64 58.21 0.27 Bn
180 BCYC Bicycle Therapeutics Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -1.42 4.41 0.27 Bn
181 ANTX AN2 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -7.21 — 0.26 Bn
182 GALT Galectin Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -9.16 — 0.26 Bn
183 CYDY CytoDyn Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -7.53 — 0.25 Bn
184 IVVD Invivyd, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.00 4.49 0.09 Bn
185 MGNX Macrogenics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -15.70 1.51 0.14 Bn
186 FIXX Q32 Bio Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 63.27 — 0.15 Bn
187 ALXO Alx Oncology Holdings Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.04 — 0.25 Bn
188 AVXL Anavex Life Sciences Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -17.50 — 0.13 Bn
189 CAMP Camp4 Therapeutics Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -4.86 57.71 0.24 Bn
190 SRZN Surrozen, Inc./DE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.81 20.18 0.23 Bn
191 CGEN Compugen Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 6.54 3.11 0.14 Bn
192 KRRO Korro Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.77 96.08 0.11 Bn
193 ALEC Alector, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.55 16.13 0.05 Bn
194 GLSI Greenwich LifeSciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -9.88 — 0.22 Bn
195 KROS Keros Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.43 6.69 -0.04 Bn
196 PLX Protalix BioTherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 10.20 2.68 0.18 Bn
197 FTH Faeth Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.09 — 0.21 Bn
198 NMRA Neumora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.30 — 0.21 Bn
199 PYXS Pyxis Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -3.19 15.19 0.18 Bn
200 PEPG PepGen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -2.92 — 0.21 Bn
201 ABOS Acumen Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.98 — 0.21 Bn
202 CHRS Coherus Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.55 4.03 0.10 Bn
203 PRQR ProQR Therapeutics N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -4.15 9.53 0.07 Bn
204 ARMP Armata Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -3.17 — 0.17 Bn
205 ORMP Oramed Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 1.14 — 0.19 Bn
206 ADAG Adagene Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -13.14 32.66 0.19 Bn
207 NBP NovaBridge Biosciences primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -2.47 — 0.19 Bn
208 CUE Cue Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.76 7.91 0.16 Bn
209 ADCT ADC Therapeutics SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.20 2.33 -0.04 Bn
210 QNCX Quince Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -2.30 — 0.17 Bn
211 XLO Xilio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -5.52 2.70 0.04 Bn
212 IPHA Innate Pharma SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.06 60.09 0.17 Bn
213 OKUR OnKure Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -2.70 — -0.01 Bn
214 MOLN Molecular Partners Ag primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -2.42 190.84 0.16 Bn
215 INDP Indaptus Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -10.49 — 0.14 Bn
216 MDWD MediWound Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -4.99 13.07 0.12 Bn
217 RANI Rani Therapeutics Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -4.69 31.59 0.15 Bn
218 NGEN Nervgen Pharma Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -116.03 — 0.15 Bn
219 MSLE Satellos Bioscience Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -2.89 — 0.15 Bn
220 MIST Milestone Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn — — -0.02 Bn
221 UNCY Unicycive Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -5.24 — 0.14 Bn
222 ENTX Entera Bio Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -9.89 — 0.13 Bn
223 IFRX InflaRx N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 1,737.03 -0.05 Bn
224 SPRB Spruce Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -2.76 — 0.13 Bn
225 HURA TuHURA Biosciences, Inc./NV primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.27 — 0.13 Bn
226 NRXP NRX Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -6.15 37.75 0.10 Bn
227 IBIO iBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -3.86 1,274.74 0.13 Bn
228 RFL Rafael Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.72 128.60 0.13 Bn
229 CNTB Connect Biopharma Holdings Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -1.79 41.93 0.12 Bn
230 PMN ProMIS Neurosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -2.87 — 0.07 Bn
231 TLSA Tiziana Life Sciences Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -6.55 — 0.12 Bn
232 BDTX Black Diamond Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -2.38 — 0.00 Bn
233 GNLX GENELUX Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -3.26 — 0.11 Bn
234 INO Inovio Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -1.37 — 0.11 Bn
235 COYA Coya Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -4.76 13.24 0.06 Bn
236 CRBP Corbus Pharmaceuticals Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn — — -0.06 Bn
237 PLYX Polaryx Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.82 — 0.09 Bn
238 RLYB Rallybio Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 2.13 150.51 0.10 Bn
239 CTOR Citius Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -2.11 60.89 0.10 Bn
240 ONCY Oncolytics Biotech Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.10 — 0.09 Bn
241 TLPH Talphera, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -6.39 90,254.65 0.09 Bn
242 ALDX Aldeyra Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.87 — 0.09 Bn
243 OTLK Outlook Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.46 — 0.08 Bn
244 RVRC Revium Rx. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -118.64 — 0.09 Bn
245 PYPD PolyPid Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 2.68 — 0.08 Bn
246 ACRV Acrivon Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.14 — 0.08 Bn
247 FBIO Fortress Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 9.80 1.19 -0.11 Bn
248 KZIA Kazia Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn — — 0.08 Bn
249 KLRS Kalaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.69 — 0.08 Bn
250 MAIA MAIA Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -2.97 — 0.05 Bn
251 CRDF Cardiff Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.83 129.70 0.08 Bn
252 ATHE Alterity Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 — 0.07 Bn
253 GANX Gain Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -3.98 — 0.07 Bn
254 TELO Telomir Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.48 — 0.07 Bn
255 SPRO Spero Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 11.51 1.42 0.02 Bn
256 XBIT XBiotech Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.59 — 0.07 Bn
257 DWTX Dogwood Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.81 — 0.07 Bn
258 HRTX Heron Therapeutics, Inc. /De/ primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -6.91 0.41 0.02 Bn
259 SCYX Scynexis Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -3.10 2.90 -0.06 Bn
260 ALGS Aligos Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.78 14.70 0.02 Bn
261 IBO Impact Biomedical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -2.83 1,519.97 0.05 Bn
262 RNTX Rein Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.06 — 0.05 Bn
263 BDRX Biodexa Pharmaceuticals Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -6.38 — 0.04 Bn
264 TIL Instil Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.28 — 0.05 Bn
265 NMAD Nomad Power Solutions, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.37 — 0.05 Bn
266 MCRB Seres Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.60 26.39 0.05 Bn
267 IMMP IMMUTEP Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.40 5.09 0.05 Bn
268 HOWL Werewolf Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.39 2.24 0.05 Bn
269 PTN Palatin Technologies Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.49 3.65 0.05 Bn
270 IMA ImageneBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn — — -0.09 Bn
271 ATYR aTYR PHARMA INC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.68 294.15 -0.01 Bn
272 EDSA Edesa Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -4.40 — 0.04 Bn
273 NXTC NextCure, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.94 — 0.04 Bn
274 ATNM Actinium Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 3.59 1.16 0.04 Bn
275 SER Serina Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.43 311.32 0.02 Bn
276 ELTX Elicio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.03 — 0.02 Bn
277 MREO Mereo BioPharma Group plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.02 78.75 0.04 Bn
278 FLNA Filana Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.62 — 0.04 Bn
279 ALP Alpha Compute Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.02 0.19 0.04 Bn
280 LITS Lite Strategy, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.66 — 0.03 Bn
281 CNTX Context Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.75 — 0.03 Bn
282 APLM Apollomics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.72 4.79 0.03 Bn
283 BHST Bioharvest Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.09 0.93 0.02 Bn
284 KYNB Kyntra Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.16 4.24 0.03 Bn
285 BETRF BetterLife Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -21.49 — 0.03 Bn
286 KAPA Kairos Pharma, LTD. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -6.19 0.38 0.03 Bn
287 BRNS Barinthus Biotherapeutics plc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.74 — 0.03 Bn
288 TAOX TAO Synergies Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.34 38.30 0.03 Bn
289 CLRB Cellectar Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.26 — 0.03 Bn
290 ADIL Adial Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.46 — 0.03 Bn
291 IGC IGC Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -12.26 93.50 0.03 Bn
292 RAPH Raphael Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -23.02 — 0.03 Bn
293 ABVC Abvc Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.55 — 0.03 Bn
294 YDESW YD Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn — — 0.02 Bn
295 VRXA Veraxa Biotech AG - Post de-SPAC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.30 869.19 0.02 Bn
296 RDPTF Radiopharm Theranostics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.28 97.58 0.02 Bn
297 LTRN Lantern Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.45 — 0.02 Bn
298 NNVC Nanoviricides, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.69 — 0.02 Bn
299 JSPR Jasper Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.10 — 0.02 Bn
300 EVAX Evaxion A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.30 2.66 0.01 Bn